Código QR (código de barras bidimensional)

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination

Abstract Objective The purpose of this study was to explore the efficacy and safety of transarterial chemoembolization (TACE) combined with apatinib and camrelizumab (TACE + AC) for unresectable hepatocellular carcinoma (HCC), and the impact of the timing of the combination on it. Methods In this si...

ver descrição completa

Na minha lista:
Principais autores: Shuguang Ju, Chen Zhou, Junwen Hu, Yingliang Wang, Chaoyang Wang, Jiacheng Liu, Chongtu Yang, Songjiang Huang, Tongqiang Li, Yang Chen, Yaowei Bai, Wei Yao, Bin Xiong
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2022-03-01
coleção:BMC Cancer
Assuntos:
Apatinib
Immunotherapy
Transarterial chemoembolization
Hepatocellular carcinoma
Prognosis
Acesso em linha:https://doi.org/10.1186/s12885-022-09451-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados